CZX

4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole

Created:	2019-05-24
Last modified:	2020-04-15

Find Related PDB Entry
4 entries where CZX is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	31
Chiral Atom Count	1
Bond Count	32
Aromatic Bond Count	11

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole
Systematic Name (OpenEye OEToolkits)	4-[(1~{S})-1-(2,3-dimethylphenyl)ethyl]-1~{H}-imidazole
Formula	C₁₃ H₁₆ N₂
Molecular Weight	200.28
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	C[CH](c1c[nH]cn1)c2cccc(C)c2C
SMILES	OpenEye OEToolkits	2.0.7	Cc1cccc(c1C)C(C)c2c[nH]cn2
Canonical SMILES	CACTVS	3.385	C[C@H](c1c[nH]cn1)c2cccc(C)c2C
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1cccc(c1C)[C@H](C)c2c[nH]cn2
InChI	InChI	1.03	InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1
InChIKey	InChI	1.03	CUHVIMMYOGQXCV-NSHDSACASA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00633
Name	Dexmedetomidine
Groups	approved investigational vet_approved
Description	An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Synonyms	(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole Dexmedetomidine hydrochloride Dextmedetomidine Dexmédétomidine Dexmedetomidin Dexmedetomidina Dexmedetomidinum dexemedetomidine Dexmed-etomidine Dexmedetomidine (+)-4-((S)-α,2,3-trimethylbenzyl)imidazole
Brand Names	Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride Dexmedetomidine in Dextrose Dexmedetomidine Hydrochloride for Injection, USP Precedex Dexmedetomidine HCI Chloride Precedex Dexmedetomidine Hydrochloride in Sodium Chloride Dexmedetomidine Hydrochloride for Injection Dexdor Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Dexmedetomidine hydrochloride Dexmedetomidine Hydrochloride Dexmedetomidine HCl Dexmedetomidine Igalmi Dexmedetomidine Accord Dexmedetomidine Hydrochloride Injection Dexmedetomidine Hydrochloride for Injection USP
Indication	Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures.[L41374] It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.[L41379]
Categories	Adrenergic Agents Adrenergic Agonists Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Agents producing tachycardia Agents that produce hypertension Analgesics Analgesics, Non-Narcotic Anesthetics Anesthetics, General Bradycardia-Causing Agents Central alpha-2 Adrenergic Agonist Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Hypnotics and Sedatives Hypotensive Agents Imidazoles Miscellaneous Anxiolytics Sedatives and Hypnotics Nervous System Neurotransmitter Agents Peripheral Nervous System Agents Psycholeptics Sensory System Agents
ATC-Code	N05CM18
CAS number	113775-47-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Alpha-2A adrenergic receptor	MFRQEQPLAEGSFAPMGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLT...	unknown	agonist
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	substrate
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	inhibitor
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	inhibitor
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682